Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Indicators for Monitoring National Drug Policies
(1999; 250 pages) [French] View the PDF document
Table of Contents
View the documentACKNOWLEDGEMENTS
Open this folder and view contentsCHAPTER I: Introduction
Open this folder and view contentsCHAPTER II: Development of the manual
Open this folder and view contentsCHAPTER III: Model lists of indicators
Open this folder and view contentsCHAPTER IV: Methodology for indicator calculation
Open this folder and view contentsCHAPTER V: Detailed presentation of indicators
Open this folder and view contentsANNEX 1: Data collection forms
View the documentANNEX 2: Glossary
View the documentANNEX 3: Table of random numbers
View the documentBACK COVER
 

BACK COVER

WHO/EDM/PAR/99.3
Original: English
Distr.: General

Many countries today are formulating and implementing comprehensive national drug policies. Such policies aim to make available effective, safe and low-cost drugs to meet the health care needs of the entire population, and to ensure that drugs are prescribed and used rationally.

Until 1994 no practical tools existed to objectively monitor progress in national drug policies or to adjust strategies on the basis of systematic assessment. That gap was filled when WHO published Indicators for Monitoring National Drug Policies. For the first time the simple and reliable indicators contained in the manual enabled countries and international agencies to assess capacity to implement a national drug policy and to monitor its implementation. In the last five years considerable experience has been gained in use of the indicators, notably in 1996. when they were systematically applied in 12 countries. Valuable feedback from around the world has been incorporated in this second edition.

The indicators are primarily intended for senior managers to assess progress towards defined targets. National policy-makers concerned with overall improvement of health conditions will find a practical tool to monitor progress in drug policy. Additionally, ministries of health (and other ministries) can select and adapt certain indicators for regular reporting on the pharmaceutical situation of their country. International agencies will find the manual useful when developing new projects in the pharmaceutical field and when assessing current projects. The standardized information provided can also help reduce duplication of effort when multiple agencies are working in one country.

Department of Essential Drugs and Medicines Policy, World Health Organization
1211 Geneva 27, Switzerland

to previous section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014